Novo invested in liver disease drug developer Mirum Pharmaceuticals as part of the round while Shire acquired an equity stake in the startup through a licensing deal.

3M Ventures has participated in a $13.7m round for VTT spinout Dispelix, which is working on augmented reality display technology.

VTT Ventures has supported a $13.7m series A round for the institute's spinout Dispelix, which is working on see-through displays.

The cognitive assessment system provider, which is backed by Gresham Lehrman Group, has raised $14.5m from new and existing investors.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Leiden University has backed a series A round co-led by Evonik and VisVires New Protein.

IU Philanthropic Venture Fund has committed $500,000 to a $2.2m bridge round for Nerx Biosciences, based on research at Indiana University.

Institut Pasteur spinout Invectys will use the funding to advance a drug candidate for a type of leukaemia into a phase 2 trial.

Archer Daniels Midland and Wilbur-Ellis have both invested in an $18.2m round for sustainable protein developer Geltor through their ADM Ventures and Cavallo Ventures units.

The lidar technology startup has secured funding in a series A round co-led by Nio's corporate venturing arm and Fidelity's Eight Roads Ventures and F-Prime Capital units.